MedTrace Logo

Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis

NCT04971798 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-07-21

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of intraarticular injection of Cell-free Stem Cell-derived Extract Formulation for treatment of knee osteoarthritis symptoms.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

Cell-free Stem Cell-derived Extract Formulation (CCM)

Intraarticular injection

Sponsors & Collaborators

  • General Therapeutics

    lead INDUSTRY

Principal Investigators

  • Craig Cady, PhD · General Therapeutics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04971798 on ClinicalTrials.gov